Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Boyd

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Pharmacology|April 9, 2020
Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and TrainingPeter D Stonier, Honorio Silva, Alan Boyd, et al.
Genetics|September 2, 2008
A random mutagenesis approach to isolate dominant-negative yeast sec1 mutants reveals a functional role for domain 3a in yeast and mammalian Sec1/Munc18 proteinsAlan Boyd, Leonora F Ciufo, Jeff W Barclay, et al.
Journal of Alzheimer'S Disease : JAD|July 11, 2022
Precision Medicine Approach to Alzheimer's Disease: Successful Pilot ProjectKat Toups, Ann Hathaway, Deborah Gordon, et al.
Journal of Alzheimer'S Disease : JAD|November 26, 2023
Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's DiseaseWon Jong Chwa, Cyrus A Raji, Kat Toups, et al.
Epilepsy & Behavior : E&B|May 6, 2021
Vinpocetine, cognition, and epilepsyKimford J Meador, Beth Leeman-Markowski, Alexandre E Medina, et al.
Epilepsy & Behavior : E&B|January 17, 2025
Cognitive and behavioral effects of perampanel 4 mg daily doseKimford J Meador, Jordan Seliger, Scheherazade Le, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2023
Precision Medicine Approach to Alzheimer's Disease: Rationale and ImplicationsDale E Bredesen, Kat Toups, Ann Hathaway, et al.
Epilepsy & Behavior : E&B|August 13, 2016
Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepineKimford J Meador, David W Loring, Alan Boyd, et al.
British Journal of Pharmacology|December 25, 2016
Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™)Scott P Webster, Andrew McBride, Margaret Binnie, et al.
Journal of Patient-Reported Outcomes|October 9, 2023
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trialChristel McMullan, Ameeta Retzer, Sarah E Hughes, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|April 9, 2020
Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and TrainingPeter D Stonier, Honorio Silva, Alan Boyd, et al.
Genetics|September 2, 2008
A random mutagenesis approach to isolate dominant-negative yeast sec1 mutants reveals a functional role for domain 3a in yeast and mammalian Sec1/Munc18 proteinsAlan Boyd, Leonora F Ciufo, Jeff W Barclay, et al.
Journal of Alzheimer'S Disease : JAD|July 11, 2022
Precision Medicine Approach to Alzheimer's Disease: Successful Pilot ProjectKat Toups, Ann Hathaway, Deborah Gordon, et al.
Journal of Alzheimer'S Disease : JAD|November 26, 2023
Longitudinal White and Gray Matter Response to Precision Medicine-Guided Intervention for Alzheimer's DiseaseWon Jong Chwa, Cyrus A Raji, Kat Toups, et al.
Epilepsy & Behavior : E&B|May 6, 2021
Vinpocetine, cognition, and epilepsyKimford J Meador, Beth Leeman-Markowski, Alexandre E Medina, et al.
Epilepsy & Behavior : E&B|January 17, 2025
Cognitive and behavioral effects of perampanel 4 mg daily doseKimford J Meador, Jordan Seliger, Scheherazade Le, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2023
Precision Medicine Approach to Alzheimer's Disease: Rationale and ImplicationsDale E Bredesen, Kat Toups, Ann Hathaway, et al.
Epilepsy & Behavior : E&B|August 13, 2016
Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepineKimford J Meador, David W Loring, Alan Boyd, et al.
British Journal of Pharmacology|December 25, 2016
Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™)Scott P Webster, Andrew McBride, Margaret Binnie, et al.
Journal of Patient-Reported Outcomes|October 9, 2023
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trialChristel McMullan, Ameeta Retzer, Sarah E Hughes, et al.
Pageof 7